International Patent: ANTI-IL-23 ANTIBODY AND USE THEREOF

GENEVA, June 26 -- SIMCERE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/138380) for “ANTI-IL-23 ANTIBODY AND USE THEREOF”. With publication no. WO/2026/119020, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....